首頁 › 閉塞性細支氣管炎症候群 › 麻薩諸塞 › Boston
Boston, MA 的 閉塞性細支氣管炎症候群 臨床試驗
13 項針對 閉塞性細支氣管炎症候群 的研究正在 Boston（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
Axatilimab for Sclerotic Chronic Graft-versus-Host Disease
招募中2 期
- Dana-Farber Cancer Institute, Boston
A Study of Belumosudil in Children With Chronic Graft Versus Host Disease (schoolROCK)
招募中2 期
- Dana-Farber Cancer Institute- Site Number : 8400007, Boston
Belumosudil for the Pre-emptive Treatment of Patients With Chronic Graft Versus Host Disease
招募中2 期
- Dana-Farber Cancer Institute, Boston
A Study to Evaluate Axatilimab and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease
招募中3 期
- Massachusetts General Hospital, Boston
- Dana Farber Cancer Institute, Boston
Observational Study for Patients at Risk for Chronic Graft-Versus-Host Disease
招募中觀察性研究
- Massachusetts Cancer Research Center, Boston
Ex Vivo-Expanded Regulatory T Cells Plus Low-Dose Interleukin-2 for Steroid-Refractory Chronic GVHD
招募中1 期
- Dana-Farber Cancer Institute, Boston
Plasma and Radiologic Biomarkers of Response to ECP in Lung Transplant Recipients With CLAD
招募中觀察性研究
- Massachusetts General Hospital, Boston
- Brigham and Women's Hospital, Boston
A Study of Axatilimab at 3 Different Doses in Participants With Chronic Graft Versus Host Disease (cGVHD)
招募中2 期
- Massachusetts General Hospital, Boston
BElumosudil for Bronchiolitis Obliterans Prevention/Therapy (BEBOP)
招募中2 期
- Dana-Farber Cancer Institute, Boston
- Boston Children's Hospital, Boston
- Brigham and Women's Hospital, Boston
A Study of Tacrolimus/Methotrexate/Ruxolitinib Versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non-Myeloablative/Reduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation (BMT CTN 2203)
招募中3 期
- Massachusetts General Hospital, Boston
- Dana Farber Cancer Institute, Boston
Impact of Exercise on the Complications of Corticosteroids in Patients With GVHD: the RESTART Trial
招募中
- Brigham and Women's Hospital, Boston
- Dana Farber Cancer Institute, Boston
A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)
招募中2 期
- Dana-Farber Cancer Institute, Boston
Prevention of GvHD in Participants With Hematological Malignancies Undergoing Hematopoietic Stem Cell Transplant (HSCT)
招募中1 期
- Dana-Farber Cancer Institute, Boston
其他城市的 閉塞性細支氣管炎症候群 試驗
- Seattle, WA11 項研究
- Atlanta, GA10 項研究
- New York City, NY9 項研究
- Houston, TX8 項研究
- Los Angeles, CA7 項研究
- Miami, FL7 項研究
- Baldwin Park, CA6 項研究
- Durham, NC6 項研究
- Tampa, FL6 項研究
- Philadelphia, PA6 項研究
- Washington, DC6 項研究
- San Francisco, CA5 項研究
Boston 的其他研究
- 乳癌112 項研究
- 非小細胞肺癌90 項研究
- 癌症（所有類型）85 項研究
- 轉移性癌症63 項研究
- 大腸直腸癌63 項研究
- 肺癌62 項研究
- 卵巢癌61 項研究
- 前列腺癌59 項研究
- 憂鬱症52 項研究
- 子宮內膜癌50 項研究
- 心臟衰竭44 項研究
- 急性髓系白血病44 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月6日。各研究自行設定資格標準；由研究團隊決定參與者資格。